Need more on ex-Sanofi CEO Viehbacher's sudden exit?

Former Sanofi CEO Chris Viehbacher

If you haven't yet read enough about ex-Sanofi ($SNY) CEO Chris Viehbacher's departure, check out Bloomberg's latest. It details the events and timeline leading up to the ousting, as well as the management-style clashes that prompted it. Story | More

 

Suggested Articles

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

Just a few months after playing a pivotal role in Sanofi’s Bioverativ buy, Alex Denner has set his sights on Ironwood.

Clovis' new approval will boost Rubraca in recurrent ovarian cancer, but because of its competitors' head start, the race will be tough.